NCT07558434: CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA
- State
- Not started
- Phase
- Phase 2
- People
- 43 planned
- Started
- Apr 2026
- Primary completion
- Dec 2028
- Arms
- CsA+EPAG/HPAG+Romiplostim N01
- Results
- None posted
- 30 Apr 2026: Trial registered